These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 32112462)

  • 1. Burden of disease of type 2 diabetes mellitus: cost of illness and quality of life estimated using the Maastricht Study.
    Janssen LMM; Hiligsmann M; Elissen AMJ; Joore MA; Schaper NC; Bosma JHA; Stehouwer CDA; Sep SJS; Koster A; Schram MT; Evers SMAA
    Diabet Med; 2020 Oct; 37(10):1759-1765. PubMed ID: 32112462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health-related quality of life for normal glycaemia, prediabetes and type 2 diabetes mellitus: Cross-sectional analysis of the ADDITION-PRO study.
    Leal J; Becker F; Feenstra T; Pagano E; Jensen TM; Vistisen D; Witte DR; Jorgensen ME
    Diabet Med; 2022 Jun; 39(6):e14825. PubMed ID: 35253278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Longitudinal changes in health-related quality of life in normal glucose tolerance, prediabetes and type 2 diabetes: results from the KORA S4/F4 cohort study.
    Hunger M; Holle R; Meisinger C; Rathmann W; Peters A; Schunk M
    Qual Life Res; 2014 Nov; 23(9):2515-20. PubMed ID: 24729056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cost-effectiveness analysis of JinQi Jiangtang tablets for the treatment on prediabetes: a randomized, double-blind, placebo-controlled, multicenter design.
    Sun X; Guo L; Shang H; Ren M; Wang Y; Huo D; Lei X; Wang H; Zhai J
    Trials; 2015 Nov; 16():496. PubMed ID: 26530718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. White Matter Connectivity Abnormalities in Prediabetes and Type 2 Diabetes: The Maastricht Study.
    Vergoossen LW; Schram MT; de Jong JJ; Stehouwer CD; Schaper NC; Henry RM; van der Kallen CJ; Dagnelie PC; van Boxtel MP; Eussen SJ; Backes WH; Jansen JF
    Diabetes Care; 2020 Jan; 43(1):201-208. PubMed ID: 31601638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Systematic Review of the Economic Burden of Type 2 Diabetes in Malaysia.
    Ganasegeran K; Hor CP; Jamil MFA; Loh HC; Noor JM; Hamid NA; Suppiah PD; Abdul Manaf MR; Ch'ng ASH; Looi I
    Int J Environ Res Public Health; 2020 Aug; 17(16):. PubMed ID: 32784771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality of life and societal costs in patients with dilated cardiomyopathy.
    Wiethoff I; Sikking M; Evers S; Gabrio A; Henkens M; Michels M; Verdonschot J; Heymans S; Hiligsmann M
    Eur Heart J Qual Care Clin Outcomes; 2024 Jun; 10(4):334-344. PubMed ID: 37709575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HypoAware-a brief and partly web-based psycho-educational group intervention for adults with type 1 and insulin-treated type 2 diabetes and problematic hypoglycaemia: design of a cost-effectiveness randomised controlled trial.
    Rondags SM; de Wit M; van Tulder MW; Diamant M; Snoek FJ
    BMC Endocr Disord; 2015 Aug; 15():43. PubMed ID: 26292674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The burden of stroke in the Netherlands: estimating quality of life and costs for 1 year poststroke.
    van Eeden M; van Heugten C; van Mastrigt GA; van Mierlo M; Visser-Meily JM; Evers SM
    BMJ Open; 2015 Nov; 5(11):e008220. PubMed ID: 26614618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measures of Left Ventricular Diastolic Function and Cardiorespiratory Fitness According to Glucose Metabolism Status: The Maastricht Study.
    Veugen MGJ; Linssen PBC; Henry RMA; Koster A; Kroon AA; Stehouwer CDA; Brunner-La Rocca HP
    J Am Heart Assoc; 2021 Jul; 10(13):e020387. PubMed ID: 34121414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Women with prior gestational diabetes mellitus and prediabetes are characterised by a decreased incretin effect.
    Foghsgaard S; Vedtofte L; Andreasen C; Andersen ES; Bahne E; Bagger JI; Svare JA; Holst JJ; Clausen TD; Mathiesen ER; Damm P; Knop FK; Vilsbøll T
    Diabetologia; 2017 Jul; 60(7):1344-1353. PubMed ID: 28364253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Economic evaluation of a lifestyle intervention in primary care to prevent type 2 diabetes mellitus and cardiovascular diseases: a randomized controlled trial.
    van Wier MF; Lakerveld J; Bot SD; Chinapaw MJ; Nijpels G; van Tulder MW
    BMC Fam Pract; 2013 Apr; 14():45. PubMed ID: 23557482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benchmarking the Cost-Effectiveness of Interventions Delaying Diabetes: A Simulation Study Based on NAVIGATOR Data.
    Leal J; Reed SD; Patel R; Rivero-Arias O; Li Y; Schulman KA; Califf RM; Holman RR; Gray AM
    Diabetes Care; 2020 Oct; 43(10):2485-2492. PubMed ID: 32796009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A cost of illness study of hypoglycaemic events in insulin-treated diabetes in the Netherlands.
    de Groot S; Enters-Weijnen CF; Geelhoed-Duijvestijn PH; Kanters TA
    BMJ Open; 2018 Mar; 8(3):e019864. PubMed ID: 29581204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Burden of disease study of overweight and obesity; the societal impact in terms of cost-of-illness and health-related quality of life.
    Hecker J; Freijer K; Hiligsmann M; Evers SMAA
    BMC Public Health; 2022 Jan; 22(1):46. PubMed ID: 34996413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Burden of illness of hip fractures in elderly Dutch patients.
    Kanters TA; van de Ree CLP; de Jongh MAC; Gosens T; Hakkaart-van Roijen L
    Arch Osteoporos; 2020 Jan; 15(1):11. PubMed ID: 31897865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-Effectiveness of a Short Message Service Intervention to Prevent Type 2 Diabetes from Impaired Glucose Tolerance.
    Wong CK; Jiao FF; Siu SC; Fung CS; Fong DY; Wong KW; Yu EY; Lo YY; Lam CL
    J Diabetes Res; 2016; 2016():1219581. PubMed ID: 26798647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation of the burden of diabetes in Poland].
    Kissimova-Skarbek K; Pach D; Płaczkiewicz E; Szurkowska M; Szybiński Z
    Pol Arch Med Wewn; 2001 Sep; 106(3):867-73. PubMed ID: 11928598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Achievable cost saving and cost-effective thresholds for diabetes prevention lifestyle interventions in people aged 65 years and older: a single-payer perspective.
    Anderson JM
    J Acad Nutr Diet; 2012 Nov; 112(11):1747-54. PubMed ID: 23102174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.